PortfoliosLab logo
TOI vs. AGL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TOI and AGL is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

TOI vs. AGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Oncology Institute, Inc. (TOI) and agilon health, inc. (AGL). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

TOI:

4.66

AGL:

-0.61

Sortino Ratio

TOI:

3.47

AGL:

-0.64

Omega Ratio

TOI:

1.43

AGL:

0.92

Calmar Ratio

TOI:

5.18

AGL:

-0.66

Martin Ratio

TOI:

14.89

AGL:

-1.23

Ulcer Index

TOI:

34.34%

AGL:

51.51%

Daily Std Dev

TOI:

130.11%

AGL:

101.28%

Max Drawdown

TOI:

-98.79%

AGL:

-96.37%

Current Drawdown

TOI:

-70.58%

AGL:

-94.84%

Fundamentals

Market Cap

TOI:

$278.41M

AGL:

$972.79M

EPS

TOI:

-$0.73

AGL:

-$0.62

PS Ratio

TOI:

0.69

AGL:

0.16

PB Ratio

TOI:

54.92

AGL:

1.85

Total Revenue (TTM)

TOI:

$403.15M

AGL:

$5.99B

Gross Profit (TTM)

TOI:

$59.28M

AGL:

-$31.93M

EBITDA (TTM)

TOI:

-$45.60M

AGL:

-$214.40M

Returns By Period

In the year-to-date period, TOI achieves a 938.83% return, which is significantly higher than AGL's 17.37% return.


TOI

YTD

938.83%

1M

28.40%

6M

1,788.24%

1Y

595.71%

3Y*

-28.33%

5Y*

N/A

10Y*

N/A

AGL

YTD

17.37%

1M

-41.32%

6M

5.69%

1Y

-61.28%

3Y*

-51.63%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


The Oncology Institute, Inc.

agilon health, inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

TOI vs. AGL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TOI
The Risk-Adjusted Performance Rank of TOI is 9797
Overall Rank
The Sharpe Ratio Rank of TOI is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of TOI is 9696
Sortino Ratio Rank
The Omega Ratio Rank of TOI is 9494
Omega Ratio Rank
The Calmar Ratio Rank of TOI is 9999
Calmar Ratio Rank
The Martin Ratio Rank of TOI is 9797
Martin Ratio Rank

AGL
The Risk-Adjusted Performance Rank of AGL is 1616
Overall Rank
The Sharpe Ratio Rank of AGL is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of AGL is 1919
Sortino Ratio Rank
The Omega Ratio Rank of AGL is 1919
Omega Ratio Rank
The Calmar Ratio Rank of AGL is 1010
Calmar Ratio Rank
The Martin Ratio Rank of AGL is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TOI vs. AGL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Oncology Institute, Inc. (TOI) and agilon health, inc. (AGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current TOI Sharpe Ratio is 4.66, which is higher than the AGL Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of TOI and AGL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

TOI vs. AGL - Dividend Comparison

Neither TOI nor AGL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TOI vs. AGL - Drawdown Comparison

The maximum TOI drawdown since its inception was -98.79%, roughly equal to the maximum AGL drawdown of -96.37%. Use the drawdown chart below to compare losses from any high point for TOI and AGL.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

TOI vs. AGL - Volatility Comparison

The Oncology Institute, Inc. (TOI) and agilon health, inc. (AGL) have volatilities of 37.39% and 37.96%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

TOI vs. AGL - Financials Comparison

This section allows you to compare key financial metrics between The Oncology Institute, Inc. and agilon health, inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20212022202320242025
104.41M
1.53B
(TOI) Total Revenue
(AGL) Total Revenue
Values in USD except per share items

TOI vs. AGL - Profitability Comparison

The chart below illustrates the profitability comparison between The Oncology Institute, Inc. and agilon health, inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%20212022202320242025
16.5%
3.3%
(TOI) Gross Margin
(AGL) Gross Margin
TOI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Oncology Institute, Inc. reported a gross profit of 17.25M and revenue of 104.41M. Therefore, the gross margin over that period was 16.5%.

AGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, agilon health, inc. reported a gross profit of 50.72M and revenue of 1.53B. Therefore, the gross margin over that period was 3.3%.

TOI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Oncology Institute, Inc. reported an operating income of -9.91M and revenue of 104.41M, resulting in an operating margin of -9.5%.

AGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, agilon health, inc. reported an operating income of -22.11M and revenue of 1.53B, resulting in an operating margin of -1.4%.

TOI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Oncology Institute, Inc. reported a net income of -19.59M and revenue of 104.41M, resulting in a net margin of -18.8%.

AGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, agilon health, inc. reported a net income of 12.11M and revenue of 1.53B, resulting in a net margin of 0.8%.